FDA Advisers Vote Against Sleep Peptide, Citing Safety Concerns
FDA advisers have voted against approving a sleep peptide, raising concerns about its safety and health claims. This decision could significantly impact the peptide industry.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)Sources
FDA advisers vote against sleep peptide as they debate safety and health claims
The FDA’s advisory committee is meeting for two days to discuss whether seven peptides — which have become popular in wellness circles — should be allowed to be compounded.
By Jaimy Lee
Read full article →Inside the unconventional FDA panel that could reshape the peptide industry
Peptides are under scrutiny in an FDA meeting running July 23-24 Olena Malik/Getty Images An unconventional FDA panel is reviewing peptide safety, focusing on banned therapeutic peptides. The FDA raised concerns over peptide safety, citing immune reactions and a lack of evidence of efficacy. Better access to peptides could open up a multibillion-dollar market for telehealth companies. Nearly 2 years after Robert F. Kennedy Jr. vowed to end the FDA's "war" on peptides, he has convened an un...
Read full article →
